Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11

被引:106
作者
Schust, DJ
Tortorella, D
Seebach, J
Phan, C
Ploegh, HL
机构
[1] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Transplantat Biol Res Ctr, Boston, MA 02119 USA
关键词
trophoblast; cytomegalovirus; human; MHC class I; HLA-G;
D O I
10.1084/jem.188.3.497
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
US11 and US2 encode gene products expressed early in the replicative cycle of human cytomegalovirus (HCMV), which cause dislocation of human and murine major histocompatibility complex (MHC) class I molecules from the lumen of the endoplasmic reticulum to the cytosol, where the class I heavy chains are rapidly degraded. Human histocompatibility leukocyte antigens (HLA)-C and HLA-G are uniquely resistant to the effects of both US11 and US2 in a human trophoblast cell line as well as in porcine endothelial cells stably transfected with human class I genes. Dislocation and degradation of MHC class I heavy chains do not appear to involve cell type-specific factors, as US11 and US2 are fully active in this xenogeneic model. Importantly, trophoblasts HLA-G and HLA-C possess unique characteristics that allow their escape from HCMV-associated MHC class I degradation. Trophoblast class I molecules could serve not only to block recognition by natural killer cells, but also to guide virus-specific HLA-C- and possibly HLA-G-restricted cytotoxic T-lymphocytes to their targets.
引用
收藏
页码:497 / 503
页数:7
相关论文
共 54 条
  • [1] The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP
    Ahn, K
    Gruhler, A
    Galocha, B
    Jones, TR
    Wiertz, EJHJ
    Ploegh, HL
    Peterson, PA
    Yang, Y
    Fruh, K
    [J]. IMMUNITY, 1997, 6 (05) : 613 - 621
  • [2] Human cytomegalovirus inhibits antigen presentation by a sequential multistep process
    Ahn, KS
    Angulo, A
    Ghazal, P
    Peterson, PA
    Yang, Y
    Fruh, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) : 10990 - 10995
  • [3] EVIDENCE FOR A POLYMORPHISM OF HLA-G GENE
    ALIZADEH, M
    LEGRAS, C
    SEMANA, G
    LEBOUTEILLER, P
    GENETET, B
    FAUCHET, R
    [J]. HUMAN IMMUNOLOGY, 1993, 38 (03) : 206 - 212
  • [4] ALTSHULER G, 1974, OBSTET GYNECOL, V43, P811
  • [5] PRODUCTION OF MONOCLONAL ANTIBODIES TO GROUP-A ERYTHROCYTES, HLA AND OTHER HUMAN CELL-SURFACE ANTIGENS - NEW TOOLS FOR GENETIC-ANALYSIS
    BARNSTABLE, CJ
    BODMER, WF
    BROWN, G
    GALFRE, G
    MILSTEIN, C
    WILLIAMS, AF
    ZIEGLER, A
    [J]. CELL, 1978, 14 (01) : 9 - 20
  • [6] BEERSMA MFC, 1993, J IMMUNOL, V151, P4455
  • [7] IN-SITU HYBRIDIZATION AND NORTHERN BLOT DEMONSTRATION OF HLA-G MESSENGER-RNA IN HUMAN TROPHOBLAST POPULATIONS BY LOCUS-SPECIFIC OLIGONUCLEOTIDE
    CHUMBLEY, G
    KING, A
    HOLMES, N
    LOKE, YW
    [J]. HUMAN IMMUNOLOGY, 1993, 37 (01) : 17 - 22
  • [8] DEWIT TFR, 1990, J IMMUNOL, V144, P1080
  • [9] DEWIT TFR, 1989, J IMMUNOGENET, V16, P391
  • [10] ELLIS SA, 1986, IMMUNOLOGY, V59, P595